State Of Wyoming Denali Therapeutics Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $23,510 - $39,623	-1,126 Reduced 99.29%	8 $0
Q1 2022 May 13, 2022	BUY	$29.0 - $47.27 $21,692 - $35,357	748 Added 193.78%	1,134 $36,000
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $13,458 - $17,386	316 Added 451.43%	386 $18,000
Q3 2021 Feb 11, 2022	SELL	$48.48 - $78.23 $12,944 - $20,887	-267 Reduced 79.23%	70 $4,000
Q2 2021 Feb 11, 2022	BUY	$50.3 - $78.44 $3,018 - $4,706	60 Added 21.66%	337 $26,000
Q1 2021 Feb 08, 2022	BUY	$53.8 - $81.53 $14,902 - $22,583	277 New	277 $16,000

241

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.78B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.